Sarah Catherine Gilbert (born April 1962) is a British vaccinologist who is Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech.
Gilbert specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011.
In April 2020, Gilbert claimed that with more funding, she could deliver a COVID-19 vaccine by September 2020.
The universal flu vaccine is a flu vaccine that is effective against all influenza strains regardless of the virus sub type, antigenic drift or antigenic shift.
Hence it should not require modification from year to year. As of 2019 there has been no approved universal flu vaccine for general use, but several have been in development...
No approved universal flu vaccine in 9 years but can easily produce a Coronavirus vaccine in no time at all?
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Co-application of fluorescent quantum dot nanocrystals and therapeutics has recently become a promising theranostic methodology for cancer treatment. We developed a tumor-targeted lipid nanocarrier that demonstrates notable efficacy in gene delivery as well as tumor bio-imaging.
Coupling of aptamer molecules against the EGF receptor (EGFR) to the distal termini of lipid nanoparticles provided the carrier with tumor-specific recognition capability.